Progression of renal insufficiency in the pre-end-stage renal disease setting;Progresión de la insuficiencia renal en pacientes con enfermedad renal crónica avanzada

Nefrologia

Volumn 23, Issue 6, 2003, Pages 510-519

  Caravaca, F ^a   Arrobas, M ^a   Luna, E ^a   Pizarro, J L ^a   Garcia C ^a   Esparrago J F ^a   Sanchez Casado E ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Anemia; Erythropoietin; Proteinuria; Renal failure progression

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UREA; ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BIOCHEMISTRY; CHRONIC KIDNEY DISEASE; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMATOCRIT; HEMATOLOGY; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PATIENT REFERRAL; PROTEINURIA; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; TIME SERIES ANALYSIS; CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TIME;

ERYTHROPOIETIN; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 3242877806     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Locatelli F, Del Vecchio L, Andrulli S, Marai P, Tentori F: The role of underlying nephropathy in the progression of renal diseases. Kidney Int (Supl. 75): S49-S55, 2000.
2. Rottey S, Vanholder R, De Schoenmakere G, Lameire N: Progression of renal failure in patients with compromised renal function is not always present: evaluation of undelying disease. Clin Nephrol 54: 1-10, 2000.
3. Locatelli F, Marcelli D, Comelli M, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A: Proteinuria and blood pressure as casual components of progression to end-stage renal failure. Nephrol Dial Transplant 11: 461-467, 1996.
4. Remuzzi G, Ruggenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 51: 12-15, 1997.
5. Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G: Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropaties. The «Gruppo Italiano di Studi Epidemiologici in Nefrologia» (GISEN). Kidney Int (Supl. 63): S54-S57, 1997.
6. Jacob L, Provoost A, Anderson S, Rennke H, Troy J, Brenner B: Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 46: 396-404, 1994.
7. Losito A, Zampi I, Fortunati I, Del Favero A: Glomerular hyperfiltration and albuminuria in essential hypertension. Nephrol 49: 84-85, 1988.
8. Alaveras AE, Thomas SM, Sagriotis A, Viberti GC: Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 12 (Supl. 2): 71-74, 1997.
9. Torffvit O, Agardh CD: The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients. J Diabetes Complications 15: 307-313, 2001.
10. Giménez L, Solez K, Walker W: Relation between renal calcium content and renal impairment in 246 human renal biopsies. Kidney Int 31: 93-99, 1987.
11. Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P: Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal inssuficiency. Nephrol Dial Transplant 12: 1908-1915, 1997.
12. Yang WQ, Song NG, Ying SS, Liang HQ, Zhang YJ, Wei MJ, Wu KF: Serum lipid concentrations correlate with the progression of chronic renal failure. Clin Lab Sci 12: 104-108, 1999.
13. Maschio O, Oldrizzi L, Tessitore N, D'Angelo Am Valvo L, Lupo A, Loschiavo C, Fabris A, Gammaro L, Rugiu C, Panzetta G: Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int 22: 371-376, 1982.
14. Ihle BU, Becker GJ, Whitworth JA, Charlwood RA, Kincaid-Smith PS: The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 321: 1773-1777, 1989.
15. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 124: 627-632, 1996.
16. Viberti G, Mogensen C, Groop L, Pauls J: Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. Br Med J 309: 833-837, 1994.
17. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334: 939-945, 1996.
18. Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetología 40: 405-411, 1997.
19. García DL, Anderson S, Rennke HG, Brenner BM: Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Aca Sci USA 85: 6142-6146, 1988.
20. Lafferty HM, García DL, Rennke HG, Troy JL, Anderson S, Brenner BM: Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension. J Am Soc Nephrol 1: 1180-1185, 1991.
21. Bellizzi V, Sabbatini M, Fuiano G, Sansone G, Magri P, Uccello F, Andreucci M, Nicola L, Cianciaruso B: The impact of early normalization of haemotocrit by erythropoietin on renal damage in remmant kidney model. Nephrol Dial Transplant 13: 2210-2215, 1998.
22. Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW Jr, Shadur CA: Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 24: 777-784, 1994.
23. Mazouz H, Kacso I, Ghazali A, El Esper N, Moriniere P, Makdassi R, Hardy P, Westeel PF, Archard JM, Pruna A, Fournier A: Risk factors of renal failure progression two years prior to dialysis. Clin Nephrol 51: 355-266, 1999.
24. Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O: Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77: 176-185, 1997.
25. Jungers P, Choukroun G, Oualim Z, Robino C, Nguyen At, Man NK: Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 16: 307-312, 2001.
26. Bergström J, Fürst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44: 1048-1057, 1993.
27. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: En: progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflamation. J Am Soc Nephrol 9: 1213-1224, 1998.
28. Norman JT, Orphanides C, García P, Line LG: Hypoxia induced changes in extracellular matrix metabolism in renal cells. Exp Nephrol 7: 463-469, 1999.
29. Orphanides C, Fine LG, Norman JT: Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta I-independent mechanism. Kidney Int 52: 637-647, 1997.
30. Sommerburg O, Grune T, Hampl H, Riedel E, Van Kuijk FJ, Ehrich JH, Siems WG: Does long-term treatment of renal anemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients? Nephrol Dial Transplant 13: 2583-2587, 1998.
31. Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellström BC: Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int 52: 985-991, 1997.
32. Jovanovic DB, Djukanovic L: Analysis of factors influencing chronic renal failure progression. Renal Fail 21: 177-187, 1999.
33. Coen G, Manni M, Giannoni MF, Bianchini G, Calabria S, Mantella D, Pigorini F, Taggi F: Ischemic nephropathy in an elderly nephrologic and hypertensive population. Am J Nephrol 18: 221-227, 1998.
34. Le Meur Y, Lorgeot V, Comte L, Szelag JC, Aldigier JC, Leroux-Robert C, Praloran V: Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoitin requirements. Am J Kidney Dis 38: 510-517, 2001.
35. Matsumura M, Nomura H, Koni I, Mabuchi H: Angiotensin-converting enzyme inhibitors are asociated with the need of increased recombinant human erythropoietin maintenance doses in hemodialysis patients. Nephron 77: 164-168, 1997.
36. Ishimura E, Nishizawa Y, Okuno S, Matsumoto N, Emoto M, Inaba M, Kawagishi T, Kim CW, Morii H: Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 11: 83-86, 1998.
37. Bosman DR, Winkler AS, Marsden JT, MacDougall IC, Watkins PJ: Anemia with erythropoietin deficiency occurs early in diabtic nephropathy. Diabetes Care 24: 495-499, 2001.